It’s Time: The Life Raft Group Biomarker Testing Campaign – Empower Patients
As part of our 'It's Time' campaign, we are sharing Blueprint Medicines's tools for talking to your doctor about biomarker/mutational testing.
As part of our 'It's Time' campaign, we are sharing Blueprint Medicines's tools for talking to your doctor about biomarker/mutational testing.
If you know your mutation, you have a better chance of getting the most effective treatment more quickly, and increasing your survival time. Knowledge makes an empowered patient and an empowered patient asks and researches their disease.
"¿Qué debo hacer si presento fátiga?" aportado por Fundación GIST México.
Our theme for 2020 was Hope. 2020 presented a challenge to us all, but most especially to our patients and caregivers who are seeking to survive this rare cancer. In 2020, The Life Raft Group needed to provide a lifeline to our community, and to offer them hope in the form of increased support as we navigate the challenges of living in a COVID-19 world. #GISTHope
It's time to shorten the time to effective treatment access. Fundación GIST Chile shares their story.
The LRG will be collaborating with the NIH again in 2021 to hold the Virtual GIST Tumor Board in place of the NIH's Pediatric & Wildtype GIST Clinic normally held in the DC area. Applications to have cases reviewed are now open.
It's time to to recognize the value of a more precise diagnosis. GISTer Jon Treder shares his story.
The Life Raft Group is delighted to welcome two phenomenal new members to our Board of Directors: Ms. Kay Stolzer and Dr. Monica (mOe) Anderson.
It's time to fully unleash the power of biomarker testing to support precision oncology - all GIST patients should have biomarker (mutational) testing for the best possible personalized treatment plan.
Each member has a unique story, but all reflect the intrinsic courage of one facing the challenge of GIST. Vicenta Salinas shares her story.